Rockville , Jan. 09, 2024 (GLOBE NEWSWIRE) -- The global human platelet lysate market is anticipated to reach $80.4 million by 2034, growing at a CAGR of 3.7% owing to rising demand in the healthcare and pharmaceutical sectors. The worldwide human platelet lysate market is expected to be worth $56.1 million in 2024.
A growth supplement for cell culture, human platelet lysate restores Fetal Bovine Serum with HPL, increasing the generation of stem cells. By doing this, bovine prions and xenogeneic possibilities are detached, which increases market demand.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9342
The platelet lysate market is undergoing a boom in research and development, notably in stem cell therapies, led by big corporations and governments. This new field is being supported and advanced by strategic actions impacting the human platelet lysate market.
Governments have made significant investments in stem cell therapy to cure various ailments, including degenerative diseases and irreversible injuries. They have encouraged public and commercial sector investment in stem cell-based treatments by providing financial incentives, research funding, and streamlined regulatory pathways.
Governments have also set ethical principles for stem cell research to ensure safety and ethics, build public confidence, and pave the road for responsible breakthroughs in stem cell treatment.
Over the projected period, the global human platelet lysate market will likely rise due to increasing mergers and acquisitions among significant competitors and higher expenditure in research & development of human platelet lysate products.
| Report Attribute | Details |
| Value Projection (2034) | US$ 80.4 million |
| Growth Rate (2024-2034) | 3.7% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 64 Tables |
| No. of Figures | 192 Figures |
Key Takeaways from the Market Study
- The global human platelet lysate market is projected to expand at a CAGR of 3.7% through 2034.
- The North America human platelet lysate market is expected to grow at a remarkable CAGR of 4.3% through 2034.
- The East-Asian human platelet lysate industry is expected to rise at a CAGR of 3.7% through 2034.
- The human platelet lysate industry in the United States holds a dominant share of 85.1% in 2024.
- China's human platelet lysate industry is expected to acquire a market share of 33.0% by 2024.
- The Heparin free platelet lysate industry dominates with 51.3% of the market share.
“The market for human platelet lysate is expected to grow steadily due to its increasing use in various fields and the acceptance of regenerative treatments. It has the potential to be a key component in innovative therapy options and medical needs resolution, bolstered by continuous biotechnology advancements and research.," opines a Fact.MR analyst.
Key Companies Profiled in This Report
- Mill Creek Lifesciences LLC
- Sclavo Diagnostics International Srl
- Stem Cell Technologies Inc.
- Lifescience Group Limited
- Macopharma SA
- Merck KGaA
- Trinova Biochem GmbH
- Zen Bio, Inc.
- AventaCell BioMedical Corp
- Compass Biomedical Inc.
Growing Demands for nerve and stem cell treatments Cure Global Human Platelet Lysate Industry
The market for human platelet lysate is broad, ranging from cutting-edge therapeutic therapies to scientific research. The market is anticipated to grow as it matures, propelled by novel technologies, treatments, and regulatory frameworks. Researchers, doctors, and patients may all access cutting-edge therapies and creative problem-solving in this dynamic setting.
Market positions have been strengthened by strategic mergers and acquisitions, particularly those involving major market participants. These transactions have enabled businesses to expand into new markets, diversify their asset portfolios, and improve their research and development resources.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9342
Country-wise Insights:-
Why does the US lead the world market for human platelet lysates?
"Platlet Lysate Applications See Growing Demand in the United States"
According to the most recent industry research by Fact.MR, the United States is expected to retain a leading market share of over 85.1% in the North American nerve repair and regeneration market by 2024.
The reason for this market expansion in this field is the rising incidence of nerve injuries, which include peripheral, spinal cord, and brain traumas, among others. These injuries are caused by a variety of factors, including accidents, sports-related injuries, and medical conditions. Due to the increasing demand for products like nerve grafts, nerve wraps, and neurostimulation devices that aid in neuron regeneration and repair, the market is growing.
With platelet lysate (PL), the benefits of steroid injections can be achieved without any negative side effects, such weakened connective tissue or lowered immune response. This makes PL a popular option for anyone seeking an anti-inflammatory medication, especially if they have experienced nerve damage. Partially due to its anti-inflammatory properties, which are essential in supporting the body's natural healing mechanisms, PL can promote segment development.
Explore More Related Studies Published by Fact.MR Research:
Platelet-Rich Plasma Market: Platelet-rich plasma uptake is poised to surge at a staggering 12% CAGR to surpass US$ 1.5 Bn by 2031.
Rheumatoid Arthritis Stem Cell Therapy Market: The Rheumatoid Arthritis Stem Cell Therapy Market is anticipated to surpass the valuation of USD 33.30 Billion by 2032.
Anti-Platelet Agents Market: Global demand for anti-platelet agents is projected to reach a market valuation of US$ 4.8 billion by the end of 2033.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
